BioSpace News Archive

Genetown

PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer

PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity ® , Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer.

December 1, 2021
·
20 min read
Business

Vitrolife announces changes to the executive management team after the acquisition of Igenomix

As announced on 30 November, 2021 , Vitrolife AB (publ) completed the acquisition of Igenomix, as a result, changes will be made to the executive management team effective 1 January, 2022.

December 1, 2021
·
1 min read
Business

Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence

Labcorp today announced a collaboration to optimize precision oncology research.

December 1, 2021
·
4 min read
Business

Alimera Sciences Welcomes Ophthalmic Strategic Consultant Erin Parsons to Its Board of Directors

Alimera Sciences, Inc. today announces the addition of Erin Parsons to its Board of Directors.

December 1, 2021
·
2 min read
Biotech Beach

Adamis Pharmaceuticals Updates Comparative Pharmacology Model Data Supporting the Higher 5 mg Intramuscular Dose of Naloxone in ZIMHI™Drug overdoses are the leading cause of death for those under age 50

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that additional data in a quantitative systems pharmacology model supports the dose of naloxone hydrochloride that is included in the company’s ZIMHI™ (naloxone HCL Injection, USP) 5 mg/0.5 mL product.

December 1, 2021
·
9 min read
Genetown

SQZ Biotechnologies Announces Acceptance by Roche Accelerator in China

SQZ Biotechnologies Company today announced that its China Initiative has been accepted by the Roche Accelerator.

December 1, 2021
·
4 min read
Business

Indaptus Therapeutics Appoints Mark Gilbert, M.D., to Board of DirectorsFormer Chief Medical Officer of Juno Therapeutics Brings Decades of Oncology Clinical Development Expertise

Indaptus Therapeutics, Inc., announces the appointment of Mark Gilbert, M.D., to its Board of Directors.

December 1, 2021
·
5 min read
Business

Freenome Partners with Siemens Healthineers for Breast Cancer Research

Freenome, a privately held biotech company, announced a partnership with Siemens Healthineers to collaborate in multiomics and radiomic breast cancer diagnostics to identify suitable markers for early breast cancer detection through blood to augment existing imaging technologies.

December 1, 2021
·
3 min read
Pharm Country

BD Issues 2021 Global Inclusion, Diversity and Equity Report

Progress Builds Strong Foundation for Bold 2030+ ESG Goals to Advance the World of Health for All.

December 1, 2021
·
4 min read
Pharm Country

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for Use in Infants and Children

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License Application (sBLA) for VAXNEUVANCE.

December 1, 2021
·
6 min read